Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 5/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 7/20 | 0.36 |
| ▸ | PDE4A | P27815 | 4/20 | 0.36 |
| ▸ | PDE4C | Q08493 | 4/20 | 0.36 |
| ▸ | TDO2 | P48775 | 1/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27176929 | 0.87 | KDM4E (0.42) | KMT2APTGER4HPGDALDH1A1KDM4E | |
| SCHEMBL27176854 | 0.86 | SLC5A7 (0.36) | KMT2ATDO2PTGER4LRRK2 | |
| SCHEMBL27205176 | 0.86 | SLC5A7 (0.36) | KMT2ATDO2PTGER4LRRK2 | |
| SCHEMBL31159781 | 0.84 | ALDH1A1 (0.43) | KMT2APDE4BPDE4DPDE4APDE4C | |
| SCHEMBL31160005 | 0.84 | HCAR3 (0.41) | KMT2AHPGDALDH1A1KDM4EMEN1 | |
| SCHEMBL30966520 | 0.84 | ALDH1A1 (0.47) | KMT2APTGER4HPGDALDH1A1KDM4E | |
| SCHEMBL24901946 | 0.82 | PTGER4 (0.43) | KMT2ATDO2PTGER4HPGDALDH1A1 | |
| SCHEMBL30232663 | 0.82 | PTGER4 (0.43) | KMT2ATDO2PTGER4HPGDALDH1A1 | |
| SCHEMBL31321908 | 0.82 | KMT2A (0.37) | KMT2ATDO2PTGER4HPGDALDH1A1 | |
| SCHEMBL27176969 | 0.82 | ALDH1A1 (0.39) | KMT2APTGER4HPGDALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4688144-A1 | COMPOUNDS AS GLP-1R AGONISTS | Terns Pharmaceuticals, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024206878-A1 | COMPOUNDS AS GLP-1R AGONISTS | TERNS PHARMACEUTICALS, INC. (US) | 2024-10-03 | — | — | WO | disclosed |